• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数、效应修饰物与胰腺癌风险:7 项前瞻性队列研究的汇总分析。

Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Cancer Causes Control. 2010 Aug;21(8):1305-14. doi: 10.1007/s10552-010-9558-x. Epub 2010 Apr 10.

DOI:10.1007/s10552-010-9558-x
PMID:20383573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2904431/
Abstract

OBJECTIVE

To investigate whether the positive association of body mass index (BMI, kg/m(2)) with risk of pancreatic cancer is modified by age, sex, smoking status, physical activity, and history of diabetes.

METHODS

In a pooled analysis of primary data of seven prospective cohorts including 458,070 men and 485,689 women, we identified 2,454 patients with incident pancreatic cancer during an average 6.9 years of follow-up. Cox proportional hazard regression models were used in data analysis.

RESULTS

In a random-effects meta-analysis, for every 5 kg/m(2) increment in BMI, the summary relative risk (RR) was 1.06 (95% confidence interval (CI) 0.99-1.13) for men and 1.12 (95% CI 1.05-1.19) for women. The aggregate analysis showed that compared with normal weight (BMI: 18.5 to <25), the adjusted RR was 1.13 (95% CI 1.03-1.23) for overweight (BMI: 25 to <30) and 1.19 (95% CI 1.05-1.35) for obesity class I (BMI: 30 to <35). Tests of interactions of BMI effects by other risk factors were not statistically significant. Every 5 kg/m(2) increment in BMI was associated with an increased risk of pancreatic cancer among never and former smokers, but not among current smokers (P-interaction = 0.08).

CONCLUSION

The present evidence suggests that a high BMI is an independent risk factor of pancreatic cancer.

摘要

目的

研究体重指数(BMI,kg/m²)与胰腺癌风险之间的正相关关系是否受年龄、性别、吸烟状况、身体活动和糖尿病史的影响。

方法

在对包括 458070 名男性和 485689 名女性在内的 7 项前瞻性队列的原始数据进行的汇总分析中,我们发现 458070 名男性和 485689 名女性在平均 6.9 年的随访中发生了 2454 例胰腺癌新发病例。数据分析采用 Cox 比例风险回归模型。

结果

在随机效应荟萃分析中,对于 BMI 每增加 5kg/m²,男性的汇总相对风险(RR)为 1.06(95%置信区间(CI)为 0.99-1.13),女性为 1.12(95%CI 为 1.05-1.19)。汇总分析表明,与正常体重(BMI:18.5 至<25)相比,超重(BMI:25 至<30)的调整 RR 为 1.13(95%CI 为 1.03-1.23),肥胖 I 级(BMI:30 至<35)为 1.19(95%CI 为 1.05-1.35)。BMI 效应与其他危险因素之间的交互作用检验无统计学意义。BMI 每增加 5kg/m²,与从不吸烟者和前吸烟者的胰腺癌风险增加相关,但与现吸烟者无关(P 交互=0.08)。

结论

现有证据表明,高 BMI 是胰腺癌的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6018/2904431/d46674cd40b6/nihms198102f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6018/2904431/e2282776a418/nihms198102f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6018/2904431/d46674cd40b6/nihms198102f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6018/2904431/e2282776a418/nihms198102f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6018/2904431/d46674cd40b6/nihms198102f2.jpg

相似文献

1
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.体重指数、效应修饰物与胰腺癌风险:7 项前瞻性队列研究的汇总分析。
Cancer Causes Control. 2010 Aug;21(8):1305-14. doi: 10.1007/s10552-010-9558-x. Epub 2010 Apr 10.
2
Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study.体重指数和身体活动作为胰腺癌的风险因素:多民族队列研究
Cancer Causes Control. 2007 Mar;18(2):165-75. doi: 10.1007/s10552-006-0100-0. Epub 2007 Jan 11.
3
[Body mass index and cancer incidence:a prospective cohort study in northern China].[体重指数与癌症发病率:中国北方的一项前瞻性队列研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6.
4
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.一生中体脂与 NIH-AARP 饮食与健康研究队列中胰腺癌风险的关系。
Am J Clin Nutr. 2013 Oct;98(4):1057-65. doi: 10.3945/ajcn.113.058123. Epub 2013 Aug 28.
5
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.体重指数与胰腺癌患者的风险、发病年龄及生存率
JAMA. 2009 Jun 24;301(24):2553-62. doi: 10.1001/jama.2009.886.
6
Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts.在瑞典两个基于人群的队列研究中,总体肥胖、腹部肥胖、糖尿病和吸烟与胰腺癌风险的关系。
Br J Cancer. 2005 Nov 28;93(11):1310-5. doi: 10.1038/sj.bjc.6602868.
7
Body mass index and risk of pancreatic cancer in a Chinese population.体重指数与中国人群胰腺癌风险的关系。
PLoS One. 2014 Jan 15;9(1):e85149. doi: 10.1371/journal.pone.0085149. eCollection 2014.
8
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.美国一个大型队列中肥胖、休闲体育活动与胰腺癌风险
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):459-66. doi: 10.1158/1055-9965.EPI-04-0583.
9
Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.体重指数、身体活动与胰腺癌风险的关系:基于吸烟状况和糖尿病史的研究——日本一项大规模人群队列研究——JPHC研究
Cancer Causes Control. 2007 Aug;18(6):603-12. doi: 10.1007/s10552-007-9002-z. Epub 2007 Mar 31.
10
Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescents.青少年超重和肥胖与男性和女性胰腺癌风险:一项针对 179 万以色列青少年的全国性研究。
Cancer. 2019 Jan 1;125(1):118-126. doi: 10.1002/cncr.31764. Epub 2018 Nov 12.

引用本文的文献

1
The Oncogenic Burden of Obesity: Mechanistic Links Between Adiposity and Gastrointestinal Cancers-A Comprehensive Narrative Review.肥胖的致癌负担:肥胖与胃肠道癌症之间的机制联系——一篇全面的叙述性综述
Biomedicines. 2025 Jun 26;13(7):1571. doi: 10.3390/biomedicines13071571.
2
A Gut Microbial Metabolite HYA Ameliorates Adipocyte Hypertrophy by Activating AMP-Activated Protein Kinase.一种肠道微生物代谢产物HYA通过激活AMP活化蛋白激酶改善脂肪细胞肥大。
Nutrients. 2025 Apr 21;17(8):1393. doi: 10.3390/nu17081393.
3
Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies.

本文引用的文献

1
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.体重指数与胰腺癌患者的风险、发病年龄及生存率
JAMA. 2009 Jun 24;301(24):2553-62. doi: 10.1001/jama.2009.886.
2
Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study.饮酒与胰腺癌风险:美国国立卫生研究院-美国退休人员协会饮食与健康研究
Am J Epidemiol. 2009 May 1;169(9):1043-51. doi: 10.1093/aje/kwp034. Epub 2009 Mar 18.
3
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
超重/肥胖与消化系统癌症的关联:一项前瞻性队列研究的荟萃分析和试验序贯分析
PLoS One. 2025 Apr 1;20(4):e0318256. doi: 10.1371/journal.pone.0318256. eCollection 2025.
4
A comparison of the burden of cancers between 1990 and 2019 in Iran: A national and subnational study.1990年至2019年伊朗癌症负担比较:一项全国及次国家级研究。
PLoS One. 2025 Feb 25;20(2):e0309699. doi: 10.1371/journal.pone.0309699. eCollection 2025.
5
The Effect of Motivation on Physical Activity among Middle and High School Students.动机对中小学生体育活动的影响。
Sports (Basel). 2024 May 30;12(6):154. doi: 10.3390/sports12060154.
6
Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, -1,-2,3,-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.多环芳烃与胰腺癌:血液生物标志物-1,2,3,4-四羟基-1,2,3,4-四氢菲与部分代谢基因单核苷酸多态性分析。
Nutrients. 2024 Feb 28;16(5):688. doi: 10.3390/nu16050688.
7
Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study.PD-1抑制剂联合吉西他滨加纳米白蛋白结合型紫杉醇治疗晚期胰腺癌的安全性和疗效分析:一项真实世界、单中心研究
Onco Targets Ther. 2023 Nov 9;16:923-935. doi: 10.2147/OTT.S427942. eCollection 2023.
8
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?胰腺癌的早期诊断:是否可行?
Cancers (Basel). 2023 Sep 5;15(18):4430. doi: 10.3390/cancers15184430.
9
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System.全国退伍军人事务医疗保健系统中的糖尿病状况与胰腺癌生存。
Dig Dis Sci. 2023 Sep;68(9):3634-3643. doi: 10.1007/s10620-023-08035-8. Epub 2023 Jul 20.
10
Short-term outcomes between robot-assisted and open pancreaticoduodenectomy in patients with high body mass index: A propensity score matched study.机器人辅助与开放胰十二指肠切除术治疗高体重指数患者的短期结局:一项倾向评分匹配研究。
Cancer Med. 2023 Jul;12(14):15141-15148. doi: 10.1002/cam4.6186. Epub 2023 May 31.
前列腺、肺、结肠直肠和卵巢癌筛查试验中血清维生素D与胰腺癌风险
Cancer Res. 2009 Feb 15;69(4):1439-47. doi: 10.1158/0008-5472.CAN-08-2694. Epub 2009 Feb 10.
4
Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada.加拿大安大略省与胰腺癌风险相关的生活方式、饮食和病史因素。
Cancer Causes Control. 2009 Aug;20(6):825-34. doi: 10.1007/s10552-009-9303-5. Epub 2009 Feb 5.
5
Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study.杂环芳香胺农药的使用与人类癌症风险:美国农业健康研究的结果
Int J Cancer. 2009 Mar 1;124(5):1206-12. doi: 10.1002/ijc.24020.
6
Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.男性吸烟者诊断前脂联素浓度与胰腺癌风险
Am J Epidemiol. 2008 Nov 1;168(9):1047-55. doi: 10.1093/aje/kwn221. Epub 2008 Sep 18.
7
Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States).绝经后女性肥胖与胰腺癌风险:美国女性健康倡议研究
Br J Cancer. 2008 Aug 5;99(3):527-31. doi: 10.1038/sj.bjc.6604487. Epub 2008 Jul 15.
8
A prospective study of physical activity and the risk of pancreatic cancer among women (United States).一项关于美国女性身体活动与胰腺癌风险的前瞻性研究。
BMC Cancer. 2008 Feb 28;8:63. doi: 10.1186/1471-2407-8-63.
9
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.体重指数与癌症发病率:前瞻性观察性研究的系统评价与荟萃分析
Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X.
10
Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort.美国国立卫生研究院-美国退休人员协会饮食与健康队列研究中的肥胖、身体活动与胰腺癌
Am J Epidemiol. 2008 Mar 1;167(5):586-97. doi: 10.1093/aje/kwm361. Epub 2008 Feb 12.